naringenin and Fibrosis

naringenin has been researched along with Fibrosis in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (75.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Li, M; Li, Q; Liu, S; Qiao, P; Xue, Q; Yang, G1
Gu, W; Mao, S; Shi, Y; Tan, Y1
Afrin, R; Arumugam, S; Harima, M; Karuppagounder, V; Nakamura, M; Pitchaimani, V; Sreedhar, R; Suzuki, H; Suzuki, K; Thandavarayan, RA; Ueno, K; Watanabe, K1
Huang, XR; Lan, HY; Li, J; Meng, XM; Ren, GL; Zhang, Y1

Other Studies

4 other study(ies) available for naringenin and Fibrosis

ArticleYear
Naringenin inhibits autophagy and epithelial-mesenchymal transition of human lens epithelial cells by regulating the Smad2/3 pathway.
    Drug development research, 2022, Volume: 83, Issue:2

    Topics: Autophagy; Cataract; Epithelial Cells; Epithelial-Mesenchymal Transition; Fibrosis; Flavanones; Humans; Signal Transduction; Smad2 Protein

2022
Naringenin inhibits allergen‑induced airway remodeling in a murine model of asthma.
    Molecular medicine reports, 2014, Volume: 9, Issue:4

    Topics: Airway Remodeling; Allergens; Animals; Asthma; Bronchial Hyperreactivity; Bronchoalveolar Lavage Fluid; Cell Differentiation; Chronic Disease; Cytokines; Disease Models, Animal; Female; Fibrosis; Flavanones; Immunoglobulin E; Inflammation; Methacholine Chloride; Mice; Mice, Inbred BALB C; Mucus; Ovalbumin; Th2 Cells

2014
Naringenin ameliorates daunorubicin induced nephrotoxicity by mitigating AT1R, ERK1/2-NFκB p65 mediated inflammation.
    International immunopharmacology, 2015, Volume: 28, Issue:1

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antibiotics, Antineoplastic; Apoptosis; Daunorubicin; Endoplasmic Reticulum Stress; Fibrosis; Flavanones; Inflammation; Injections, Intravenous; Kidney Diseases; Male; MAP Kinase Signaling System; PPAR gamma; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Renal Agents; Transcription Factor RelA

2015
Treatment of renal fibrosis by rebalancing TGF-β/Smad signaling with the combination of asiatic acid and naringenin.
    Oncotarget, 2015, Nov-10, Volume: 6, Issue:35

    Topics: Animals; Blotting, Western; Drug Therapy, Combination; Estrogen Antagonists; Fibrosis; Flavanones; Gene Expression Regulation; Immunoenzyme Techniques; Kidney Diseases; Male; Mice; Mice, Inbred C57BL; Pentacyclic Triterpenes; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Signal Transduction; Smad3 Protein; Transforming Growth Factor beta

2015